In order to fully understand the mechanism(s) of drug resistance that accompany induction of EMT in NSCLC cells, we investigated CSC markers (Sox2, Nanog and EpCAM) and the expression levels of several EMT-related miRNAs in parental A549 vs. mesenchymal A549M cells. The gene discussed is SOX2; the disease is non-small cell lung carcinoma.